Yasuo Fujii

Directeur/Membre du Conseil chez ORCHARD THERAPEUTICS PLC

Health Technology

Consumer Services

Profil

Yasuo Fujii is Director at Orchard Therapeutics Plc since 2024.
Mr. Fujii is Chief Strategy Officer at Kyowa Kirin Co., Ltd. since 2023.
Formerly, Mr. Fujii was Executive Vice President-Corporate Planning at Kyowa Kirin International Plc.
Mr. Fujii earned an MBA from the University of Illinois.

Postes actifs de Yasuo Fujii

Sociétés	Poste	Début
KYOWA KIRIN CO., LTD.	Corporate Officer/Principal	01/04/1988
ORCHARD THERAPEUTICS PLC	Directeur/Membre du Conseil	24/01/2024

Tous les postes actifs de Yasuo Fujii

Anciens postes connus de Yasuo Fujii

Sociétés	Poste	Fin
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Corporate Officer/Principal	-

Voir l'expérience en détail de Yasuo Fujii

Formation de Yasuo Fujii

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Yasuo Fujii

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Kyowa Kirin International Plc Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes antibodies, cell & gene therapies for hematological, bone, mineral, haemato-oncology and rare diseases	Health Technology
University of Illinois University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Kyowa Kirin Co., Ltd. Kyowa Kirin Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals; develops biochemical reagents and other chemicals	Health Technology
Orchard Therapeutics Plc Orchard Therapeutics Plc BiotechnologyHealth Technology Engages in research and advancements of gene therapy to develop potential cures for genetic & other severe diseases	Health Technology